Clinical Trial Update: Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial from Memorial Sloan Kettering Cancer Center evaluating lesion dosimetry using the radioactive tracer Iodine-124 in metastatic t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Iodine-124 (Iodine-124)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Thyroid Carcinoma, Metastatic Thyroid Carcinoma | Phase 1 | Status: RECRUITING